Rotavirus (vaccine)

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, RotavirusRotavirus Infections

Phase 2

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

CompletedNCT00346892

GlaxoSmithKlineRotavirus Infections

Start: 2001-11-30Target: 450Updated: 2016-09-09

Phase 3

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

CompletedNCT00140686

GlaxoSmithKlineInfections, Rotavirus

Start: 2004-09-30End: 2006-08-31Updated: 2017-03-23

Related Papers

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, <i>Rotarix</i>™: A retrospective laboratory analysis

Human Vaccines & Immunotherapeutics2016-09-228 citations

Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination

Human Vaccines & Immunotherapeutics2016-06-0347 citations

Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.

2008-09-0968 citations

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.

2007-11-01466 citations